Anogenital Wart

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anogenital Wart trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 7 trials

RecruitingNot Applicable

NCT07234838

Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)

This study aims to assess the impact of anti-TNF-α, anti-IL-17, and anti-IL-23 biologic therapies on the risk of development or recurrence of anogenital warts (…

Belgium600 participantsStarted 2026-02-01

RecruitingPhase 2

NCT06756269

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

To evaluate the safety and Immunogenicity of 15-valent HPV vaccine in 9-45year-old participants.

China330 participantsStarted 2025-01-15

Treatment: Medium dose for 15-HPV vaccine, High dose for 15-HPV vaccine

RecruitingNot Applicable

NCT02520986

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

In a randomized clinical trial of 114 women undergoing Treatment for condyloma acuminata, two surgical methods, the carbon dioxide laser Ablation and the excisi…

Germany114 participantsStarted 2016-12

Treatment: Carbon dioxide Laser ablation, Electrocoagulation

RecruitingPhase 3

NCT04422366

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

This study is designed to evaluate the vaccine efficacy, immunogenicity and safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58)…

China8,000 participantsStarted 2020-04-28

Treatment: 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARDASIL®

RecruitingPhase 3

NCT04895020

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

This phase 3 study will evaluate the immunogenicity and safety of 9-valent HPV recombinant vaccine in Chinese females aged 9 to 45 years

China1,200 participantsStarted 2021-05-28

Treatment: 9-valent HPV vaccine

RecruitingNot Applicable

NCT05371353

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

To access the immune persistence of Chinese women aged 9-45 years after receiving quadrivalent HPV vaccine with the immunization schedule of 0, 2 and 6 months.

China600 participantsStarted 2022-05-14

All recent trials (100 shown)

Not Yet RecruitingEarly Phase 1

NCT07396714

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

To compare between the efficacy and safety of topical ivermectin alone, microneedling with topical ivermectin and topical salicylic acid in treatment of cutaneo…

Location not specified88 participantsStarted 2026-02-01

Treatment: Ivermectin, microneedling

CompletedPhase 3

NCT02750202

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Large genital warts are frequently diagnosed in general gynaecology and oncology clinics in South Africa. Medical and destructive therapy for small warts is gen…

South Africa52 participantsStarted 2018-07-01

Treatment: Quadrivalent HPV vaccine, Hepatitis B vaccine

Anogenital Wart

Trial phase breakdown

Trial status

Actively recruiting — 7 trials

Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

All recent trials (100 shown)

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Trial phase breakdown

Trial status

Actively recruiting — 7 trials

Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

All recent trials (100 shown)

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Intralesional HPV Vaccine for Condylomata

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Ty…

Impact Of Intralesional Tuberculin Ppd Injection On Anogenital

Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts

Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)

Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure

Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study

Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient

Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata

Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old